Online citations, reference lists, and bibliographies.

Dissemination Of Intraperitoneal Ovarian Cancer: Discussion Of Mechanisms And Demonstration Of Lymphatic Spreading In Ovarian Cancer Model.

A. Feki, P. Berardi, G. Bellingan, A. Major, K. Krause, P. Petignat, Rubab Zehra, S. Pervaiz, I. Irminger-Finger
Published 2009 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
Ovarian cancer is often accompanied by severe ascites. This complication aggravates the disease per se and the chances for its successful treatment. The etiology of ascites is not well understood nor are efficient therapies for ascites available. These empirical observations support the view that ascites might be caused by blocking of lymphatic vessels. Furthermore, it suggests that cancer cells might be the blocking agent and could use lymphatic vessels for metastatic spreading. To test this hypothesis, we used labeled cancer cells in an immuno-competent animal model of ovarian cancer and followed their dissemination. These NuTu-19 cells are ovarian cancer cells derived from normal rat ovarian epithelial cells, the origin of the most frequent ovarian cancer. Thus studying NuTu-19 cell behavior in an animal model is likely to reflect the progression of the human disease. To unambiguously document the migration of NuTu-19 cells from the peritoneum to remote organs, we generated EGFP expressing NuTu-19 cells by transduction with EGFP-lentiviral vectors. The EGFP positive NuTu-19 cells were injected intraperitoneally into immuno-competent FISHER 344 rats, and the metastatic spreading was monitored. Metastases were observed on the peritoneum, the omentum and in the parathymus. This clearly demonstrates that systemic spreading of NuTu-19 ovarian cancer cells is conducted by lymphatic ways. Animals die 7 weeks after injection, with severe ascites, which suggests that blockage of lymphatic drainage by the cancer cell growth is an important complication of the disease.
This paper references
10.1023/A:1023791229361
Intraperitoneal cancer dissemination: Mechanisms of the patterns of spread
C. Pablo Carmignani (2004)
6-[18F]fluoro-L-fucose: a possible tracer for assessing glycoconjugate synthesis in tumors with positron emission tomography.
Kiichi Ishiwata (1990)
The cellular composition of omentum milky spots and the ultrastructure of milky spot macrophages and reticulum cells.
Robert H J Beelen (1980)
10.1080/10937400701876095
Risk Factors for Ovarian Cancer: An Overview with Emphasis on Hormonal Factors
F. Salehi (2008)
10.1097/COC.0b013e318134ee6f
For Women Receiving Chemotherapy for Clinically Apparent Early Ovarian Cancer, Is There a Benefit to Surgical Staging?
Don S Dizon (2008)
10.1002/ijc.1571
Estimates of the world-wide prevalence of cancer for 25 sites in the adult population.
Paola Pisani (2002)
10.1002/(SICI)1097-0142(19990101)85:1<178::AID-CNCR25>3.0.CO;2-7
Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
A. Kraft (1999)
10.1038/nbt0997-871
Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo
R. Zufferey (1997)
10.1172/JCI33775
The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin.
H. Kenny (2008)
10.1152/ajprenal.00313.2004
The transport barrier in intraperitoneal therapy.
M. Flessner (2005)
10.1016/0090-8258(89)90109-1
Utilization of a murine model to optimize volume and dwell time of intraperitoneal cisplatin.
Robert G. Pretorius (1989)
Diagnosing ascitic etiology on a biochemical basis.
Shaifali Bansal (1998)
10.1016/S0002-9440(10)64467-7
Vascular endothelial growth factor immunoneutralization plus Paclitaxel markedly reduces tumor burden and ascites in athymic mouse model of ovarian cancer.
L. Hu (2002)
Spontaneous transformation of rat ovarian surface epithelial cells results in well to poorly differentiated tumors with a parallel range of cytogenetic complexity.
Joseph R. Testa (1994)
10.1016/S0959-8049(01)00350-1
Estimates of cancer incidence and mortality in Europe in 1995.
F. Bray (2002)
10.3892/ijo.16.3.445
Inhibition of malignant ascites and growth of human ovarian carcinoma by oral administration of a potent inhibitor of the vascular endothelial growth factor receptor tyrosine kinases.
L. Xu (2000)
In vivo and in vitro studies of experimental ovarian adenocarcinoma in rats.
Souei Sekiya (1979)
10.1053/ob.1996.v175.a73595
Development and characterization of a clinically useful animal model of epithelial ovarian cancer in the Fischer 344 rat.
G. Scott Rose (1996)
10.1007/978-3-540-37696-5_9
Prevention and early detection of ovarian cancer: mission impossible?
R. Bast (2007)
10.1002/cncr.9048
Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
David C. Chhieng (2001)
10.1200/JCO.2007.11.5345
Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: a Gynecologic Oncology Group Study.
Robert Burger (2007)
Human ovarian carcinoma metastatic models constructed in nude mice by orthotopic transplantation of histologically-intact patient specimens.
X Y Fu (1993)
10.1016/S0002-9440(10)65669-6
Role of vascular endothelial growth factor in ovarian cancer: inhibition of ascites formation by immunoneutralization.
Sam Mesiano (1998)
10.1016/S1470-2045(06)70939-1
Mechanisms of transcoelomic metastasis in ovarian cancer.
David Sp Tan (2006)
10.1210/edrv.22.2.0422
Ovarian surface epithelium: biology, endocrinology, and pathology.
N. Auersperg (2001)
10.1016/J.YGYNO.2007.10.017
The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass.
R. Moore (2008)
10.1038/bjc.1998.1
United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) Guidelines for the Welfare of Animals in Experimental Neoplasia (Second Edition).
N. J. McNally (1998)
Ovarian cancer screening.
D. Neesham (2007)
10.1093/annonc/mdl498
Estimates of the cancer incidence and mortality in Europe in 2006.
Jacques Ferlay (2006)
10.1186/1471-2407-8-31
The impact of comorbidity and stage on ovarian cancer mortality: A nationwide Danish cohort study
Mette Skytte Tetsche (2007)
In vivo fate of the inflammatory macrophage during the resolution of inflammation: inflammatory macrophages do not die locally, but emigrate to the draining lymph nodes.
G. J. Bellingan (1996)
10.1016/j.ygyno.2007.09.014
Metastatic lymph node number in epithelial ovarian carcinoma: does it have any clinical significance?
Ali Ayhan (2008)
10.1038/ncponc0342
Angiogenic inhibitors: a new therapeutic strategy in oncology
G. Gasparini (2005)
10.1128/jvi.72.11.8463-8471.1998
A Third-Generation Lentivirus Vector with a Conditional Packaging System
T. Dull (1998)
10.1038/nrc745
New functions for the matrix metalloproteinases in cancer progression
M. Egeblad (2002)
10.1016/j.ejca.2009.12.014
Estimates of cancer incidence and mortality in Europe in 2008.
Jacques Ferlay (2010)
10.1002/hep.1840080521
Ascitic fluid analysis in malignancy-related ascites.
Bruce Allen Runyon (1988)
10.1056/nejmra041842
Cancer of the ovary.
S. Cannistra (2004)
Involvement of SDF-1alpha/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma.
Hiroaki Kajiyama (2008)
10.1007/978-1-4613-1247-5_6
Observations concerning cancer spread within the peritoneal cavity and concepts supporting an ordered pathophysiology.
P. Sugarbaker (1996)



This paper is referenced by
Etude de l’impact de la vitronectine et de la fibronectine ascitiques sur la récidive des carcinomes ovariens
Lyvia Blay (2016)
10.18632/oncotarget.5159
BCAT1 expression associates with ovarian cancer progression: possible implications in altered disease metabolism
Z. Wang (2015)
10.1097/COC.0000000000000119
Assessment of False-negative Ascites Cytology in Epithelial Ovarian Carcinoma: A Study of 313 Patients
Valerie A Allen (2017)
A LOCALIZED CONTROLLED DELIVERY SYSTEM UTILIZING A BLOCK COPOLYMER TO IMPROVE THE CURRENT PARADIGM OF CHEMOTHERAPY
Jason Olbrich (2013)
10.1186/1757-2215-7-22
HE4 tumor marker concentration in neoplastic peritoneal effusion and in peritoneal fluid associated with benign gynecological diseases
Anita Chudecka-Głaz (2014)
10.1038/onc.2012.632
Aurora kinase A mediates epithelial ovarian cancer cell migration and adhesion
T-V Do (2014)
10.1016/j.ejca.2013.03.016
Ovarian cancer: Ion channel and aquaporin expression as novel targets of clinical potential.
Julia Frede (2013)
10.1097/IGC.0b013e3182150e98
Tissue Factor-Factor VIIa Complex Induces Epithelial Ovarian Cancer Cell Invasion and Metastasis Through a Monocytes-Dependent Mechanism
Zhengwen Ma (2011)
10.1002/ijc.31887
Inhibition of Ca2+ -activated chloride channel ANO1 suppresses ovarian cancer through inactivating PI3K/Akt signaling.
Zongtao Liu (2019)
Aktuelle Aspekte der operativen Therapie des epithelialen Ovarialkarzinoms
Werner Lichtenegger (2009)
10.3390/cancers11071008
The Role of Cancer Stem Cells and Mechanical Forces in Ovarian Cancer Metastasis
Michael E. Bregenzer (2019)
10.1016/j.fct.2012.11.004
Antitumor effect and toxicity of Lipusu in rat ovarian cancer xenografts.
Liang Ye (2013)
10.3892/or.2014.3243
Aberrant hypomethylation-mediated AGR2 overexpression induces an aggressive phenotype in ovarian cancer cells.
Hye Youn Sung (2014)
10.1016/j.jcpa.2012.03.006
Primary ovarian rhabdomyosarcoma in a dog.
Jankerle N Boeloni (2012)
10.1007/s00761-014-2684-4
Welche Bedeutung hat die Qualität der Operation auf die Prognose beim Ovarialkarzinom?
Christina Fotopoulou (2014)
10.3349/ymj.2014.55.6.1656
DNA Hypomethylation-Mediated Overexpression of Carbonic Anhydrase 9 Induces an Aggressive Phenotype in Ovarian Cancer Cells
Hye Youn Sung (2014)
10.1016/j.bbrc.2017.10.050
Construction of artificial human peritoneal tissue by cell-accumulation technique and its application for visualizing morphological dynamics of cancer peritoneal metastasis.
Yoshiya Asano (2017)
10.1038/nrclinonc.2010.47
Imaging ovarian cancer and peritoneal metastases—current and emerging techniques
Stavroula Kyriazi (2010)
10.1007/s13402-020-00513-9
Current insights into the metastasis of epithelial ovarian cancer - hopes and hurdles
Meysam Yousefi (2020)
10.1051/MMNP/20105109
Individual Cell-Based Model for In-Vitro Mesothelial Invasion of Ovarian Cancer
Chiara Giverso (2010)
10.5317/WJOG.V2.I4.101
Cytoreductive surgery after recurrent epithelial ovarian cancer and at other timepoints
Paolo Sammartino (2013)
10.1007/978-981-10-7053-2_8
Combined Resection Liver Metastases and Peritoneal Metastases
A. Ariche (2018)
10.2147/OTT.S216355
Tumor-Associated Macrophages (TAMs): A Critical Activator In Ovarian Cancer Metastasis
Meichen Yin (2019)
10.3389/fonc.2013.00256
Getting to Know Ovarian Cancer Ascites: Opportunities for Targeted Therapy-Based Translational Research
N. Ahmed (2013)
10.18632/oncotarget.19714
Hic-5 regulates epithelial to mesenchymal transition in ovarian cancer cells in a TGFβ1-independent manner
Razan Sheta (2017)
10.3390/jcm9040924
Flow-induced Shear Stress Confers Resistance to Carboplatin in an Adherent Three-Dimensional Model for Ovarian Cancer: A Role for EGFR-Targeted Photoimmunotherapy Informed by Physical Stress
Shubhankar Nath (2020)
10.1016/j.ejso.2011.10.006
Prognostic factors for and prognostic value of mesenteric lymph node involvement in advanced-stage ovarian cancer.
Sébastien Gouy (2012)
10.3892/or.2016.4835
Synaptotagmin-like protein 2 gene promotes the metastatic potential in ovarian cancer.
Hye Youn Sung (2016)
Quimioterapia intraperitoneal hipertérmica con técnica cerrada y sistema de recirculación de CO2 para el tratamiento de carcinomatosis peritoneal
Susana Sánchez García (2014)
10.1016/j.procbio.2020.04.006
Systematic and validated techniques for the detection of ovarian cancer emphasizing the electro-analytical approach
Nigar Anzar (2020)
10.1152/ajpcell.00188.2015
Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis.
Tsz-Lun Yeung (2015)
Establishment and characterization of McA ‐ RH 7777 cells using virus ‐ mediated stable overexpression of enhanced green fluorescent protein
Wei Zhang (2018)
See more
Semantic Scholar Logo Some data provided by SemanticScholar